21 Jul, 2021 UK revealed as Europe's fastest growing hub for cannabis investment By Dylan Kennett DLA Piper's European Cannabis team in partnership with Hanway Associates, Crunchbase and Seedrs have analysed the European cannabis...
15 Jul, 2021 DLA Piper Report - The COVID-19 pandemic and the pharmaceutical and medical sector in Poland By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Our report 'The COVID-19 pandemic and the pharmaceutical and medical sector in Poland' is the first that brings together the...
13 Jul, 2021 Use of preventive care services declined despite expanded coverage By Kirsten Axelsen Key Points: For the privately insured, Medicare, and uninsured populations, the prevalence of the use of preventive care services...
09 Jul, 2021 FDA solicits public comment on adding list of device materials to certain medical device labels By Meagan Self Mary Gately Christopher Campbell Since the 1930s, the Food and Drug Administration has required food manufacturers to list each ingredient in a food product by its common...
08 Jul, 2021 DOJ Should Weigh Dismissing Every Nonintervened FCA Suit - Law360 By Courtney Saleski Eric Christofferson Andrew Hoffman When the U.S. Department of Justice chooses not to intervene in a False Claims Act qui tam lawsuit, it should also evaluate whether...
08 Jul, 2021 Judgment in Case C-178/20 - Pharma Expressz By Mariana Ricardo On 8 July the Court of Justice of the European Union (CJEU) issued its judgement in Case C-178/20, concerning the placement on the market...
06 Jul, 2021 What COVID-19, Social Issues Mean For Pharma Case Juries - Law360 By Buffy Mimms Rachel Horton Recent surveys of actual and potential jurors suggest that the turbulence of this time will likely affect the attitudes of juries in...
06 Jul, 2021 Poland: A revolutionary draft amendment to the Reimbursement Act By Amelia Prawda Jolanta Dabrowicz Andrzej Balicki, Ph.D. On 30 June 2021, a draft bill amending the Act of 12 May 2011 on the Reimbursement of Medicines, Foodstuffs for Special Nutritional...